Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1

OBJECTIVES: Evaluate long-term rates of virological failure and treatment interruption for people living with HIV (PLWHIV) with viral suppression on first-line efavirenz + tenofovir disoproxil fumarate + emtricitabine/lamivudine (EFV + TDF + FTC/3TC), and compare these according to patient character...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410964/
https://www.ncbi.nlm.nih.gov/pubmed/30829745
http://dx.doi.org/10.1097/QAD.0000000000002126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410964/
https://www.ncbi.nlm.nih.gov/pubmed/30829745
http://dx.doi.org/10.1097/QAD.0000000000002126

Ejemplares similares